Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Prf Technologies Ltd (PRFX)

Prf Technologies Ltd (PRFX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BladeRanger to Showcase Advanced Green Energy Technologies at Abu Dhabi Sustainability Week PR Newswire - Tue Dec 30, 2025

AI-driven monitoring and analytics solutions addressing the growing demand for energy efficiency in large-scale solar and critical infrastructure projects across the Middle East.

PRFX : 1.9300 (-2.03%)
PainReform Ltd. Reports Partial Topline Data from Phase 3 Trial of PRF-110 for Post-Surgical Pain Management Quiver Quantitative, Inc. - Wed Nov 20, 2024

PainReform reports positive Phase 3 trial findings for PRF-110 in postoperative pain but faces data inconsistencies for key metrics.Quiver AI SummaryPainReform Ltd. announced the receipt of partial topline...

PRFX : 1.9300 (-2.03%)
PainReform to Present at the Microcap Conference in Atlantic City Newsfile - Mon Jan 22, 2024

Tel Aviv, Israel--(Newsfile Corp. - January 22, 2024) - PainReform Ltd. (NASDAQ: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of...

PRFX : 1.9300 (-2.03%)

Barchart Exclusives

Pinterest Stock Skyrockets on Better-Than-Expected Earnings. Here's Why It's Not Too Late to Buy Barchart - 1 hour ago
Pinterest stock pushes higher on strong Q1 earnings and impressive future guidance. But there’s reason to believe that PINS shares will rip higher from here as the year unfolds. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.